BioGaia AB (publ) at its AGM held on May 5, 2023 approved a dividend of SEK 1.45 per share for 2022, a grant of SEK 4.4 million to "The Foundation to Prevent Antibiotic Resistance" that was founded by BioGaia in 2017.